Search / 167 results found

  • Updated

MONDAY, Aug. 1, 2022 (HealthDay News) -- A considerable proportion of products remain available for purchase after issuance of U.S. Food and Drug Administration warning letters targeting specific supplement products, according to a research letter published in the July 26 issue of the Journal of the American Medical Association.